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Background
Nigeria and the Democratic Republic of Congo (DRC)
together account for one-third of the estimated global
total of malaria cases and 40% of malaria deaths. Improv-
ing health system performance in these countries is critical
for reducing the global malaria burden. In both countries,
fever treatment-seeking in the private sector is very com-
mon. Antimalarial medicine outlet surveys conducted in
Nigeria and the DRC in 2009 documented antimalarial
markets dominated by informal drug stores and high non-
artemisinin monotherapy (non-AMT) availability and
market share, as well as moderate availability of oral
AMT. 2011 findings from Nigeria showed improved arte-
misinin combination therapy (ACT) availability and mar-
ket share, but continued availability and distribution of
oral AMT. 2013 data were collected to inform and moni-
tor ongoing strategy and funding decisions to improve
malaria case management.
Materials and methods
Antimalarial medicine outlet surveys were conducted as
part of the ACTwatch project (http://www.actwatch.info)
in Nigeria and the DRC in 2013. A census of all outlets
with the potential to sell/distribute antimalarials was con-
ducted within a representative sample of clusters (national
in Nigeria, Kinshasa & Katanga provinces in the DRC).
Drug information, sale/distribution in the previous week,
and retail price were collected for every antimalarial in
stock. Product and distribution information was used to
calculate relative market share using the adult equivalent
treatment dose as the unit of analysis.
Results
The overwhelming majority of antimalarial-stocking out-
lets in the DRC and Nigeria were drug stores. In both
countries, non-AMT (quinine in the DRC, chloroquine
in Nigeria) and ACT were commonly in stock among
antimalarial-stocking drug stores. While ACT availability
was high, many drug stores in both countries were
stocking non-quality-assured (QA) ACT. Oral AMT was
commonly available among drug stores in Nigeria, but
very rarely available in the DRC. The vast majority of
antimalarials sold/distributed across study sites were dis-
tributed through drug stores. ACT (including non-QA
ACT) accounted for less than half of the antimalarial
market share in both countries. Non-AMT (SP, quinine,
chloroquine) accounted for more than half of the mar-
ket share across study sites.
Conclusions
Informal drug stores continue to dominate the antima-
larial markets in the DRC and Nigeria in terms of absolute
number of service delivery points, and sale/distribution
of treatments. Consumers seeking care at antimalarial-
stocking drug stores will commonly find both non-AMT
and ACT available. However, non-QA ACT is frequently
available and distributed. Oral AMT availability continues
to be of concern in Nigeria.
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